276 related articles for article (PubMed ID: 34638654)
1. RHAMM Is a Multifunctional Protein That Regulates Cancer Progression.
Messam BJ; Tolg C; McCarthy JB; Nelson AC; Turley EA
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638654
[TBL] [Abstract][Full Text] [Related]
2. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo SE; He Y; Daughters C; Knutson TP; Henzler CM; Price MA; Shanley R; Witschen P; Tolg C; Kaspar RE; Hallstrom C; Gittsovich L; Sulciner ML; Zhang X; Forster CL; Lange CA; Shats O; Desler M; Cowan KH; Yee D; Schwertfeger KL; Turley EA; McCarthy JB; Nelson AC
J Pathol; 2023 Jul; 260(3):289-303. PubMed ID: 37186300
[TBL] [Abstract][Full Text] [Related]
3. Increased RHAMM expression relates to ovarian cancer progression.
Buttermore ST; Hoffman MS; Kumar A; Champeaux A; Nicosia SV; Kruk PA
J Ovarian Res; 2017 Sep; 10(1):66. PubMed ID: 28954627
[TBL] [Abstract][Full Text] [Related]
4. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
5. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.
Shigeishi H; Higashikawa K; Takechi M
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1629-40. PubMed ID: 24676428
[TBL] [Abstract][Full Text] [Related]
6. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
[TBL] [Abstract][Full Text] [Related]
7. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
8. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.
Nikitovic D; Kouvidi K; Karamanos NK; Tzanakakis GN
Biomed Res Int; 2013; 2013():929531. PubMed ID: 24083250
[TBL] [Abstract][Full Text] [Related]
9. CD44 and RHAMM Are Microenvironmental Sensors with Dual Metastasis Promoter and Suppressor Functions.
Tolg C; Hill KA; Turley EA
Adv Biol (Weinh); 2024 Jun; 8(6):e2300693. PubMed ID: 38638002
[TBL] [Abstract][Full Text] [Related]
10. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
[TBL] [Abstract][Full Text] [Related]
12. Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling.
Ma X; Pearce JD; Wilson DB; English WP; Edwards MS; Geary RL
J Vasc Surg; 2014 Mar; 59(3):804-13. PubMed ID: 23768790
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor.
He Z; Mei L; Connell M; Maxwell CA
Cells; 2020 Mar; 9(4):. PubMed ID: 32231069
[TBL] [Abstract][Full Text] [Related]
14. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
15. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
[TBL] [Abstract][Full Text] [Related]
16. Developmental regulation of hyaluronan-binding protein (RHAMM/IHABP) expression in early bovine embryos.
Stojkovic M; Krebs O; Kölle S; Prelle K; Assmann V; Zakhartchenko V; Sinowatz F; Wolf E
Biol Reprod; 2003 Jan; 68(1):60-6. PubMed ID: 12493696
[TBL] [Abstract][Full Text] [Related]
17. Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain.
Lynn BD; Li X; Cattini PA; Turley EA; Nagy JI
J Comp Neurol; 2001 Oct; 439(3):315-30. PubMed ID: 11596057
[TBL] [Abstract][Full Text] [Related]
18. Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis.
Du YC; Chou CK; Klimstra DS; Varmus H
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16753-8. PubMed ID: 21940500
[TBL] [Abstract][Full Text] [Related]
19. The receptor for hyaluronan-mediated motility (RHAMM) expression in neonatal bronchiolar epithelium correlates negatively with lung air content.
Markasz L; Savani RC; Sedin G; Sindelar R
Early Hum Dev; 2018 Dec; 127():58-68. PubMed ID: 30312861
[TBL] [Abstract][Full Text] [Related]
20. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.
Savani RC; Cao G; Pooler PM; Zaman A; Zhou Z; DeLisser HM
J Biol Chem; 2001 Sep; 276(39):36770-8. PubMed ID: 11448954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]